Khan Naveed Wali, Hassan Fouzia, Naqvi Baqar S, Hasan Syed Muhammad Farid
Department of Pharmaceutics, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan.
Pak J Pharm Sci. 2011 Jan;24(1):25-9.
Fifty clinical isolates comprising of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus were collected from different local pathological laboratories and their resistant pattern against two well known macrolides; erythromycin and clarithromycin were studied using disc diffusion method. Klebsiella (41.67% against erythromycin and 58.34% against clarithromycin) and Proteus (66.67% against erythromycin and clarithromycin) species were found to be more resistant against the studied macrolides as compared to the rest of organisms. In case of Staphylococcus aureus and Escherichia.coli, resistant found were 27.78% and 23.54% against erythromycin and 22.23% and 35.30% against clarithromycin respectively. It is concluded from these figures that microbial resistance against these macrolides are increasing in our population which is alarming and therefore it is recommended to physicians to prescribe these antibiotics unless no other substitute is available in clinical practices.
从不同的当地病理实验室收集了50株临床分离株,包括大肠杆菌、金黄色葡萄球菌、克雷伯菌和变形杆菌,并使用纸片扩散法研究了它们对两种著名大环内酯类药物(红霉素和克拉霉素)的耐药模式。与其他微生物相比,克雷伯菌(对红霉素的耐药率为41.67%,对克拉霉素的耐药率为58.34%)和变形杆菌(对红霉素和克拉霉素的耐药率均为66.67%)对所研究的大环内酯类药物的耐药性更强。在金黄色葡萄球菌和大肠杆菌中,对红霉素的耐药率分别为27.78%和23.54%,对克拉霉素的耐药率分别为22.23%和35.30%。从这些数据可以得出结论,我们人群中对这些大环内酯类药物的微生物耐药性正在增加,这令人担忧,因此建议医生除非在临床实践中没有其他替代品,否则不要开这些抗生素。